Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Milestone Scientific (MLSS) EBIT (2016 - 2025)

Milestone Scientific's EBIT history spans 16 years, with the latest figure at -$1.1 million for Q3 2025.

  • For Q3 2025, EBIT rose 25.1% year-over-year to -$1.1 million; the TTM value through Sep 2025 reached -$6.7 million, changed 0.3%, while the annual FY2024 figure was -$6.8 million, 4.31% up from the prior year.
  • EBIT for Q3 2025 was -$1.1 million at Milestone Scientific, up from -$1.5 million in the prior quarter.
  • Across five years, EBIT topped out at -$984373.0 in Q1 2021 and bottomed at -$2.9 million in Q2 2022.
  • The 5-year median for EBIT is -$1.9 million (2022), against an average of -$1.8 million.
  • The largest annual shift saw EBIT surged 38.81% in 2021 before it crashed 94.49% in 2022.
  • A 5-year view of EBIT shows it stood at -$1.5 million in 2021, then decreased by 28.98% to -$2.0 million in 2022, then increased by 0.38% to -$2.0 million in 2023, then dropped by 5.34% to -$2.1 million in 2024, then surged by 45.6% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for MLSS's EBIT are -$1.1 million (Q3 2025), -$1.5 million (Q2 2025), and -$2.0 million (Q1 2025).